Enjoy complimentary customisation on priority with our Enterprise License!
The insulin syringes market is projected to grow by USD 408.67 million with a CAGR of 4.69% during the forecast period 2021 to 2026.
This insulin syringes market research report provides valuable insights on the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers insulin syringes market segmentation by disease type (type 2 diabetes and type 1 diabetes) and geography (North America, Europe, APAC, South America, and the Middle East and Africa). The insulin syringes market report also offers information on several market vendors, including AdvaCare Pharma, ASP Healthcare Pty Ltd., Avantor Inc., B. Braun SE, Becton Dickinson and Co., Cardinal Health Inc, CODAN Medizinische Gerate GmbH and Co KG, Gerresheimer AG, Healthwarehouse.com Inc., Hi-Tech Medics Pvt Ltd., Hindustan Syringes and Medical Devices Ltd., LAC Healthcare Solutions, Nipro Corp., Novo Nordisk AS, Poly Medicure Ltd., SCHOTT AG, Smiths Group Plc, Terumo Corp., Thermo Fisher Scientific Inc., and UltiMed Inc. among others.
Download Report Sample to Unlock the Insulin Syringes Market Size for the Forecast Period and Other Important Statistics
The rising global burden of diabetes is notably driving the insulin syringes market growth, although factors such as non-adherence to insulin regimens may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic's impact on the insulin syringes market industry. The holistic analysis of the drivers will help in deducing the end goals and refining marketing strategies to gain a competitive edge.
Key Insulin Syringes Market Driver
Key Insulin Syringes Market Trend
Key Insulin Syringes Market Challenge
This insulin syringes market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Technavio categorizes the global insulin syringes market as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the insulin syringes market during the forecast period.
The report analyzes the market’s competitive landscape and offers information on several market vendors, including:
This statistical study of the insulin syringes market encompasses successful business strategies deployed by the key vendors. The insulin syringes market is fragmented, and the vendors are deploying organic and inorganic growth strategies to compete in the market.
To make the most of the opportunities and recover from the post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments while maintaining their positions in the slow-growing segments.
The vendor profiles are designed to help clients improve their market position, and the information on production and sustainability along with this report provides a detailed analysis of several leading Companies.
Our In-house experts produce extensive information on the value chain and parent market of the insulin syringes market, which vendors can leverage to gain a competitive advantage during the forecast period. The Value Chain information provides an end-end understanding of product insight and profit and also optimization and evaluation of business strategies The players across the value chain includes selective data and analysis from entire research findings as per the scope of the report.
For more insights on the market share of various regions, Request PDF Sample now!
43% of the market’s growth will originate from North America during the forecast period. The US and Canada are the key markets for the insulin syringes market in North America. Market growth in this region will be faster than the growth of the market in other regions.
The increase in technological advances will facilitate the insulin syringes market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID-19 Impact and Recovery Analysis
The adoption of insulin syringe systems declined slightly due to the outbreak of COVID-19. However, by the second half of 2020, the restrictions in various countries were somewhat relaxed due to the lifting of the lockdowns. Thus, the relaxation of such restrictions will encourage people to go for health checkups and treatments, which will drive the growth of the market during the forecast period.
To gain further insights on the market contribution of various segments Request PDF Sample
The insulin syringes market share growth in the type-2 diabetes segment will be significant during the forecast period. Patients with type-2 diabetes commonly use insulin syringes to deliver insulin subcutaneously. Insulin syringes are classified into various types based on the needle length, needle gauge, and syringe capacity. Vendors are offering a wide array of syringes of different sizes for type 2 diabetes. These devices are available at affordable prices and are covered under reimbursement policies, which is driving the segment growth.
This report provides an accurate prediction of the contribution of all the segments to the growth of the insulin syringes market size and actionable market insights on the post-COVID-19 impact on each segment.
|
Insulin Syringes Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
120 |
|
Base year |
2021 |
|
Forecast period |
2022-2026 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 4.69% |
|
Market growth 2022-2026 |
$408.67 million |
|
Market structure |
Fragmented |
|
YoY growth (%) |
4.55 |
|
Regional analysis |
North America, Europe, APAC, South America, and the Middle East and Africa |
|
Performing market contribution |
North America at 43% |
|
Key consumer countries |
US, Canada, China, Germany, and France |
|
Competitive landscape |
Leading companies, Competitive Strategies, Consumer engagement scope |
|
Key companies profiled |
AdvaCare Pharma, ASP Healthcare Pty Ltd., Avantor Inc., B. Braun SE, Becton Dickinson and Co., Cardinal Health Inc, CODAN Medizinische Gerate GmbH and Co KG, Gerresheimer AG, Healthwarehouse.com Inc., Hi-Tech Medics Pvt Ltd., Hindustan Syringes and Medical Devices Ltd., LAC Healthcare Solutions, Nipro Corp., Novo Nordisk AS, Poly Medicure Ltd., SCHOTT AG, Smiths Group Plc, Terumo Corp., Thermo Fisher Scientific Inc., and UltiMed Inc. |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Disease Type
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Certified ISO 9001 : 2015
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
Let us help you make report more suited to your requirements.
Get the report (PDF) sent to your email within minutes.
